Open Access
Article
Transverse Myelitis: pathogenesis, diagnosis and treatment
Chitra Krishnan1,Adam I Kaplin1,Deepa M Deshpande1,Carlos A Pardo1,Douglas A Kerr1
1
Department of Neurology, Johns Hopkins Transverse Myelitis Center, 600 N. Wolfe Street Pathology 627C, Baltimore MD 21287-6965, USA. ckrishn1@jhmi.edu
DOI: 10.2741/1351 Volume 9 Issue 2, pp.1483-1499
Published: 01 May 2004
(This article belongs to the Special Issue Inflammatory disorders of the nervous system)
Abstract

Transverse Myelitis (TM) is a clinical syndrome in which an immune-mediated process causes neural injury to the spinal cord, resulting in varying degrees of weakness, sensory alterations and autonomic dysfunction. TM may exist as part of a multi-focal CNS disease (e.g. MS), multi-systemic disease (e.g. systemic lupus erythematosus), or as an isolated, idiopathic entity. In this article, we will summarize recent classification and diagnostic schemes (1), which provide a framework for the acute management of patients with TM. Additionally, we will review current concepts on the natural history, immunopathogenesis and treatment strategies for patients with TM.

Share and Cite
Chitra Krishnan, Adam I Kaplin, Deepa M Deshpande, Carlos A Pardo, Douglas A Kerr. Transverse Myelitis: pathogenesis, diagnosis and treatment. Frontiers in Bioscience-Landmark. 2004. 9(2); 1483-1499.